Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-5,6-dihydro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-
2. 8-chloro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-5,6-dihydro-4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine
1. 1228088-30-9
2. Rg7314
3. Ro5285119
4. Balovaptan [inn]
5. Balovaptan [usan]
6. Rax5d5agv6
7. Rg-7314
8. Ro-5285119
9. 8-chloro-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
10. 4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-5,6-dihydro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-
11. 8-chloro-5-methyl-1-{trans-4-[(pyridin-2-yl)oxy]cyclohexyl}-5,6-dihydro-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
12. Balovaptan (usan/inn)
13. Balovaptan [usan:inn]
14. Unii-rax5d5agv6
15. Balovaptan [who-dd]
16. Schembl2471320
17. Schembl3329710
18. Schembl3332136
19. Chembl4297183
20. Gtpl10615
21. Dtxsid101107286
22. Bdbm50546439
23. Akos037648594
24. Compound 1 [pmid: 31951127]
25. Db14823
26. Sb19643
27. Bs-14780
28. Hy-109024
29. Cs-0030526
30. D11476
31. D80511
32. 12-chloro-8-methyl-3-[(1r,4r)-4-(pyridin-2-yloxy)cyclohexyl]-2,4,5,8-tetraazatricyclo[8.4.0.0(2),]tetradeca-1(10),3,5,11,13-pentaene
33. 8-chloro-5,6-dihydro-5-methyl-1-[trans-4-(2-pyridinyloxy)cyclohexyl]-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
34. 8-chloro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-5,6-dihydro-4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine
35. 8-chloro-5-methyl-1-(trans-4-(pyridin-2-yloxy)cyclohexyl)-5,6-dihydro-4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine
| Molecular Weight | 409.9 g/mol |
|---|---|
| Molecular Formula | C22H24ClN5O |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 409.1669381 g/mol |
| Monoisotopic Mass | 409.1669381 g/mol |
| Topological Polar Surface Area | 56.1 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 545 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of autism spectrum disorder
Antidiuretic Hormone Receptor Antagonists
Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)
ABOUT THIS PAGE
18
PharmaCompass offers a list of Balovaptan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Balovaptan manufacturer or Balovaptan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Balovaptan manufacturer or Balovaptan supplier.
PharmaCompass also assists you with knowing the Balovaptan API Price utilized in the formulation of products. Balovaptan API Price is not always fixed or binding as the Balovaptan Price is obtained through a variety of data sources. The Balovaptan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Balovaptan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Balovaptan, including repackagers and relabelers. The FDA regulates Balovaptan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Balovaptan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Balovaptan supplier is an individual or a company that provides Balovaptan active pharmaceutical ingredient (API) or Balovaptan finished formulations upon request. The Balovaptan suppliers may include Balovaptan API manufacturers, exporters, distributors and traders.
Balovaptan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Balovaptan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Balovaptan GMP manufacturer or Balovaptan GMP API supplier for your needs.
A Balovaptan CoA (Certificate of Analysis) is a formal document that attests to Balovaptan's compliance with Balovaptan specifications and serves as a tool for batch-level quality control.
Balovaptan CoA mostly includes findings from lab analyses of a specific batch. For each Balovaptan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Balovaptan may be tested according to a variety of international standards, such as European Pharmacopoeia (Balovaptan EP), Balovaptan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Balovaptan USP).
